Angiotensin II and TGF-β in the development of cardiac fibrosis, myocyte hypertrophy, and heart failure

Heart Failure Reviews

Volumn 2, Issue 2, 1997, Pages 107-116

  Dixon, Ian M C ^a   Reid, Nicole L ^a   Ju, Haisong ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; DRUG RECEPTOR BINDING; EFFECTOR CELL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; MEMBRANE BINDING; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031448462     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009771910953     Document Type: Review

References (111)

1. Pfeffer JM, Fisher TA, Pfeffer MA. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu Rev Physiol 1995;57:805-826.
2. Eghbali-Webb M, Sigel A. Role of transforming growth factor betal in the remodeling of collagen matrix in the heart. In Dhalla NS, Pierce GN, Panagia V, Beamish RE, eds. Heart Hypertrophy and Failure. Boston: Kluwer Academic, Publishers, 1995;287-297.
3. Brand T, Schneider MD. The TGF beta superfamily in myocardium: ligands, receptors, transduction, and function. J Mol Cell Cardiol 1995;27:5-18.
4. Long CS. Autocrine and paracrine regulation of myocardial cell growth in vitro. The TGF-β paradigm. Trends Cardiovasc Med 1996;6:217-226.
5. Dostal DE, Baker KM. Biochemistry, molecular biology, and potential roles of the cardiac renin-angiotensin system. In Dhalla NS, Beamish RE, Takeda N, Nagano M, eds. The Failing Heart. Philadelphia: Lippincott-Raven, Publishers, 1995:275-294.
6. Danser AHJ. Local renin-angiotensin systems. Mol Cell Biochem 1996;157:211-216.
7. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993;75:977-984.
8. Dostal DE, Rothblum KG, Conrad KM, Cooper GR, Baker KM. Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts: evidence for local production. Am J Physiol 1992;263:C851-C863.
9. Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 1996;334:1649-1654.
10. Steinberg MI, Wiest SA, Plakowitz AD. Nonpeptide angiotensin II receptor antagonists. Cardiovasc Drug Rev 1993;11:312-358.
11. Wong PC, Hart SD, Zaspel AM, et al. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: Dup 753 (AII-1) and PD123177 (AII-2). J Pharmocol Exp Ther 1990;255:584-592.
12. Griendling KK, Lassegue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol 1996;36:281-306.
13. Clauser E, Curnow KM, Davies E, et al. Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements. Eur J Endocrinol 1996; 134:403-411.
14. Matsubara H, Kanasaki M, Murasawa S, Tsukuguchi Y, Nio Y, Inada M. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest 1994;93:1592-1601.
15. Shanmugam S, Corvol P, Gase J-M. Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension 1996;28:91-97.
16. Inagami T. Recent progress in molecular and cell biological studies of angiotensin receptors. Curr Opin Nephrol Hypertens 1995;4:47-54.
17. Bottari SP, Taylor V, King IN, Bogdal Y, Whitebread S, de Gasparo M. Angiotensin II AT2 receptors do not interact with guanine nucleotide binding proteins. Eur J Pharmacol 1991;207:157-163.
18. 3 in the rat fetus. J Biol Chem 1996; 271:15026-15033.
19. Crabos M, Roth M, Hahn AWA, Erne P. Characterization of angiotensin II receptors in cultured rat cardiac fibroblasts. J Clin Invest 1994;93:2372-2378.
20. Kim NN, Villarreal FJ, Printz MP, Lee AA, Dillmann WH. Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts. Am J Physiol 1995;269:E426-E437.
21. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996;93:156-160.
22. Stoll M, Steckelings M, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995;95:651-657.
23. Nakajima M, Hutchinson HG, Fujinaga M, et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 1995;92:10663-10667.
24. Ichiki T, Labosky PA, Shiota C, et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995;377:748-750.
25. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 1995;377:744-747.
26. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995; 95:46-54.
27. Booz GW, Baker KM. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res 1995;30:537-543.
28. Neer EJ. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995;80:249-257.
29. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993;73:413-423.
30. Baker KM, Aceto JA. Characterization of avian angiotensin II cardiac receptors: coupling to mechanical activity and phosphoinositide metabolism. J Mol Cell Cardiol 1989;21:375-382.
31. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-614.
32. Sadoshima J, Qui Z, Morgan JP, Izumo S. Angiotensin II and other hypertrophie stimuli mediated by G protein-coupled receptors activated tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. Circ Res 1995;76:1-15.
33. Bogoyevitch MA, Glennon PE, Andersson MB, et al. Endothelin-1 and fibroblast growth factor stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes: the potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem 1994;269:1110-1119.
34. Schorb W, Conrad KM, Singer HA, Dostal DE, Baker KM. Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J Mol Cell Cardiol 1995;27:1151-1160.
35. 2+ in angiotensin II-induced mitogenesis of cardiac fibroblasts. Am J Physiol 1994;267: C1308-C1318.
36. Schorb W, Peeler TC, Madigan NN, Conrad KM, Baker KM. Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J Biol Chem 1994;269:19626-19632.
37. Schunkert H, Sadoshima J, Cornelius T, et al. Angiotensin II-induced growth responses in isolated adult rat hearts. Evidence for load-independent induction of cardiac proteins synthesis by angiotensin II. Circ Res 1995;76:489-497.
38. 1 receptor. Nature 1995;375:247-250.
39. Schieffer B, Paxton WG, Marrero MB, Bernstein KE. Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signaling. Hypertension 1996;27:476-480.
40. 1A receptor activates transcription factor stat91 and/or a related protein. J Biol Chem 1994;269:31443-31449.
41. Griendling KK, Delafontaine P, Rittenhouse SE, Gimbrone MAJ, Alexander RW Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin II-stimulated cultured vascular smooth muscle cells. J Biol Chem 1987;262:14555-14562.
42. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597-641.
43. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-β receptor. Nature 1994;370:341-347.
44. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1287-1292.
45. Roberts AB, Sporn MB. The transforming growth factor-β. In Sporn MB, Roberts AB, eds. Peptide Growth Factors and Their Receptors. Heidelberg: Springer-Verlag, 1990:419-472.
46. Engelmann GL, Boehm KD, Birchenall-Roberts MC, Ruscetti FW Transforming growth factor-β in heart development. Mechan Dev 1992;38:85-98.
47. Eghbali M. Cellular origin and distribution of transforming growth factor-β1 in the normal rat myocardium. Cell Tissue Res 1989;256:553-558.
48. Chua CC, Diglio CA, Siu BB, Chua BHL. Angiotensin II induces TGF-β1 production in rat heart endothelial cells. Biochim Biophys Acta 1994;1223:141-147.
49. Lee AA, Dillmann WH, McCulloch AD, Villarreal FJ. Angiotensin II stimulates the autocrine production of transforming growth factor-βl in adult rat cardiac fibroblasts. J Mol Cell Cardiol 1995;27:2347-2357.
50. Flanders KG, Winokur TS, Holder MG, Sporn MB. Hyperthermia induces expression of transforming growth factor-β in rat cardiac cells in vitro and in vivo. J Clin Invest 1993;92:404-410.
51. Takahashi N, Calderone A, Izzo NJJ, Maki TM, Marsh JD, Colucci WS. Hypertrophie stimuli induce transforming growth factor-β 1 expression in rat ventricular myocytes. J Clin Invest 1994;94:1470-1476.
52. McMahon GA, Digam JD, Gentry LE. Structural characterization of the latent complex between transforming growth factor β1 and β1-latency-associated peptide. Biochem J 1996;313:343-351.
53. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB. Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: regulation of plasminogen activator activity. J Cell Biol 1992;118:901-909.
54. Attisano L, Wrana JL, Lopez-Castillas F, Massague J. TGF-β receptors and actions. Biochim Biophys Acta 1994;1222:71-80.
55. Engelmann GL, Grutkoski PS. Coordinate TGF-β receptor gene expression during rat heart development. Cell Mol Biol Res 1994;40:93-104.
56. Ross J, Janero DR, Hreniuk D. Identification and biochemical characterization of a heart-muscle cell transforming growth factor β1 receptor. Biochem Pharmacol 1993;46:511-516.
57. Ross J, Janero DR, Hreniuk D. Identification and molecular characterization of a high-affinity cardiomyocyte transforming growth factor-β2 receptor. FEBS Lett 1993;320:229-234.
58. Sigel AV, Centrella M, Eghbali-Webb M. Regulation of proliferative response of cardiac fibroblasts by transforming growth factor-β1. J Mol Cell Cardiol 1996;28:1921-1929.
59. Wrana JL, Attisano L, Carcamo J, et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 1992;71:1003-1014.
60. Massague J. TGF-β signaling: receptors, transducers, and Mad proteins. Cell 1996;85:947-950.
61. Weiser R, Wrana JL, Massague J. GS domain mutations that constitutively active T β R-I, the downstream signaling component in the TGF-β receptor complex. EMBO J 1995; 14:2199-2208.
62. Brand T, MacLellan WR, Schneider MD. A dominant-negative receptor for type-beta transforming growth factors created by deletion of the kinase domain. J Biol Chem 1993; 268:11500-11503.
63. Sankar S, Mahooti-Brooks N, Centrella M, McCarthy TL, Madri JA. Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor β2. J Biol Chem 1995;270:13567-13572.
64. Kaname S, Ruoslahti E. Betaglycan has multiple binding sites for transforming growth factor-β1. Biochem J 1996; 315:815-820.
65. Baker JC, Harland RM. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev 1996;10:1880-1889.
66. Hoodless PA, Haerry T, Abdollah S, et al. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 1996;85:489-500.
67. Liu F, Hata A, Baker JC, et al. A human Mad protein acting as a BMP-regulated transcriptional activator [see comments]. Nature 1996;381:620-623.
68. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 1996;87:1215-1224.
69. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia. Autocrine transforming growth factor-β, expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-461.
70. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993;91:2268-2274.
71. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1419-1424.
72. Antonipillai I, Le TH, Soceneantu L, Horton R. Transforming growth factor-β is a renin secretagogue at picomolar concentrations. Am J Physiol 1993;265:F537-F541.
73. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-1865.
74. Khairallah PA, Kanabus J. Angiotensin and myocardial protein synthesis. Perspect Cardiovasc Res 1983;8:337-347.
75. Sadoshima J-I, Izumo S. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Circ Res 1993;73:424-438.
76. Kijima K, Matsubara H, Murasawa S, et al. Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. Circ Res 1996;79:887-897.
77. Lee Y-A, Liang C-S, Lee M-A, Lindpainter K. Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog. Proc Natl Acad Sci USA 1996;93:11035-11040.
78. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993;153:937-942.
79. Schunkert H, Tang SS, Litwin SE, et al. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovasc Res 1993;27:731-735.
80. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-828.
81. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-677.
82. Pfeffer JM, Pfeffer MA, Steinberg C. Survival after an experimental myocardial infarction: beneficial effects of longterm therapy with captopril. Circulation 1985;72:406-412.
83. McDonald KM, Mock J, D'Alioa A, et al. Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis. Circulation 1995;91:2043-2048.
84. Johnston CI. Angiotensin receptor antagonists: focus on losartan. Lancet 1995;346:1403-1407.
85. Milavetz JJ, Raya TE, Johnson CS, Morkin E, Goldman S. Survival after myocardial infarction in rats: captopril versus losartan. J Am Coll Cardiol 1996;27:714-719.
86. Makino N, Hata T, Sugano M, Dixon IMC, Yanaga T. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. J Mol Cell Cardiol 1996;28:507-517.
87. Long CS, Henrich CJ, Simpson PC. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Reg 1991;2:1081-1095.
88. Parker TG, Packer SE, Schneider MD. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest 1990;85:507-514.
89. Schluter K-D, Zhou XJ, Piper HM. Induction of hypertrophic responsiveness to isoproterenol by TGF-β in adult rat cardiomyocytes. Am J Physiol 1995;269:C1311-C1316.
90. Miki N, Hamamori Y, Hirata K, et al. Transforming growth factor-β1 potentiated α1-adrenergic and stretch-Induced c-fos mRNA expression in rat myocardial cells. Circ Res 1994;75:8-14.
91. Eghbali M, Tomek R, Sukhatme VP, Woods C, Bhambi B. Differential effects of transforming growth factor-β1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res 1991;69:483-490.
92. 1 expression. Hypertension 1994;23:587-592.
93. 1, fibronectin, and collagen. Am J Physiol 1992;262:H1861-H1866.
94. Weber KT, Sun Y, Tyagi SC, Cleutjens JPM. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 1994; 26:279-292.
95. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26:809-820.
96. Ju H, Dixon IMC. Effect of angiotensin II on myocardial collagen gene expression. Mol Cell Biochem 1996;163/ 164:231-237.
97. Brecher P. Angiotensin II and cardiac fibrosis. Trends Cardiovasc Med 1996;6:193-198.
98. Schieffer B, Wirger A, Meybrunn M, et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994;89:2273-2282.
99. Smits JFM, vanKrimpen C, Shoemaker RG, Cleutjens JPM, Daemen MJAP. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 1992;20:772-778.
100. van Krimpen C, Smits JFM, Cleutjens JPM, et al. DNA synthesis in the non-infareted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol 1991;23:1245-1253.
101. Sun Y, Weber KT. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res 1994; 28:1623-1628.
102. Sun Y, Cleutjens JP, Diaz-Arias AA, Weber KT. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 1994;28:1423-1432.
103. Chua CC, Chua BHL, Zhao CZY, Krebs C, Diglio C, Perrin E. Effect of growth factors on collagen metabolism in cultured human heart fibroblasts. Connect Tissue Res 1991;26:271-281.
104. Heimer R, Bashey RI, Kyle J, Jimenez SA. TGF-β modulates the synthesis of proteoglycans by myocardial fibroblasts in culture. J Mol Cell Cardiol 1995;27:2191-2198.
105. Thompson NL. Transforming growth factor beta-1 in acute myocardial infarction in rats. Growth Factors 1988; 1:91-99.
106. Kerr LD, Miller DB, Matrisian LM. TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell 1990;61:267-278.
107. Cleutjens JPM, Kandala JC, Guarda E, Guntaka RV, Weber KT. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 1995;27:1281-1292.
108. Dixon IMC, Ju H, Jassal DS, Peterson DJ. Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction. Mol Cell Biochem 1996;165:31-45.
109. Qian SW, Kondaiah P, Casscells W, Roberts AB, Sporn MB. A second messenger RNA species of transforming growth factor β1 in infarcted rat heart. Cell Reg 1991;2:241-249.
110. Ju H, Dixon IMC. Extracellular matrix and cardiovascular diseases. Can J Cardiol 1996;12:1259-1267.
111. Robinson TF, Factor SM, Sonnenblick EH. The heart as a suction pump. Sci Am 1986;254:84-91.